Lovacef 50 mg/ml Zawiesina do wstrzykiwań
Lovacef 50 mg/ml Zawiesina do wstrzykiwań
Authorised
- Ceftiofur
Product identification
Medicine name:
Lovacef 50 mg/ml Zawiesina do wstrzykiwań
Active substance:
- Ceftiofur
Target species:
-
Pig
-
Cattle
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Ceftiofur50.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Pig
-
Meat and offal2day
-
-
Cattle
-
Meat and offal6day
-
Milk0day
-
-
-
Intramuscular use
-
Pig
-
Meat and offal2day
-
-
Cattle
-
Meat and offal6day
-
Milk0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DD90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Package description:
- Available only in Polish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Lovapharm Consulting B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Interchemie Werken De Adelaar B.V.
- Interchemie Werken De Adelaar Eesti AS
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 2986
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 7/02/2023
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 7/02/2023
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022